HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of tumor lysis syndrome in patients with multiple myeloma during bortezomib treatment.

AbstractBACKGROUND:
Tumor lysis syndrome (TLS) is a severe, life-threatening complication that typically occurs in highly proliferative malignancies. Although TLS is unusual in multiple myeloma (MM), it is still associated with significant morbidity. Bortezomib has been widely used for the treatment of MM with encouraging results, but TLS seems to occur more frequently in patients with MM receiving bortezomib than in patients receiving other conventional agents.
OBJECTIVES:
The purpose of this article is to present and examine several significant risk factors for the development of TLS, based on the results of a study involving patients with MM who developed TLS during bortezomib treatment.
METHODS:
Patients with MM were treated with bortezomib-containing regimens.
FINDINGS:
The early identification and intervention of high-risk patients with MM is imperative. Timely and efficient management could decrease TLS incidence rates and improve the efficacy of treatment outcomes.
AuthorsLi Wang, Yuan Jian, Guangzhong Yang, Wen Gao, Yin Wu, Lihong Zuo
JournalClinical journal of oncology nursing (Clin J Oncol Nurs) Vol. 19 Issue 1 Pg. E4-7 (Feb 2015) ISSN: 1538-067X [Electronic] United States
PMID25689664 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Bortezomib
Topics
  • Aged
  • Antineoplastic Agents (adverse effects)
  • Bortezomib (adverse effects)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma (drug therapy)
  • Risk Factors
  • Tumor Lysis Syndrome (diagnosis, etiology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: